Being on active surveillance: the patient perspective

Prostate cancer (PCa) patients selected for active surveillance (AS) have received information on prostate cancer PCa, treatment, knew their serum prostate specific antigen (PSA), a digital rectal examination (DRE) done and could rely on their set of biopsies to be labelled as low grade, low volume disease (by adding a radiographic/ultrasonic measurement). They usually react euphoric to the selection hoping to escape invasive curative treatment and its side-effects. Unfortunately, this positive feeling waivers in front of uncertainty in the follow-up including biopsies. Improvements on prognostics are needed. The patients need reassuring information and confidence building to keep his choice to AS based on evidence and confidence.

Translational andrology and urology. 2018 Feb [Epub]

Ken Mastris, Louis Denis

Europa Uomo, Antwerp, Belgium., Oncology Centre Antwerp, Europa Uomo, Antwerp, Belgium.

email news signup